Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

Sci Adv. 2022 Mar 25;8(12):eabh4050. doi: 10.1126/sciadv.abh4050. Epub 2022 Mar 23.

Abstract

Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adoptive Transfer
  • Animals
  • Humans
  • Immunity
  • Interleukin-8* / immunology
  • Interleukin-8* / metabolism
  • Killer Cells, Natural* / immunology
  • Mice
  • Neoplasms* / immunology
  • Neoplasms* / radiotherapy
  • Xenograft Model Antitumor Assays

Substances

  • CXCL8 protein, human
  • Interleukin-8